Women: More Prone to Lower Coronary Flow Reserve

Compared to men, women have less chances of developing obstructive coronary artery disease (CAD), but this new study suggests they are more prone to have lower coronary flow reserve, which is also a risk factor.

 

Evidently, ischemic cardiomyopathy entails far more than assessing and treating plaque burden in epicardial arteries. In women, the most prevalent pathological phenotype was low coronary flow reserve in absence of OBSTRUCTIVE CAD, while in men, most of patients presenting low coronary flow reserve had multiple vessels disease. 

 

This study, simultaneously published in Circulation, assessed 329 patients (43% women) referred for a coronary angiography after positive stress test and > 40% ejection fraction.

 

Regardless of their similar age, cardiovascular medication and ischemia extension, women had lower pretest clinical risk, with lower rates of MI and burden of angiographic CAD, compared to men.

 

Moreover, women also presented less obstructive CAD and lower revascularization rate. Despite of traditional scores, women had higher risk of events at 3 years.

 

After adjusting for epicardial disease, women continued to have higher events risk than men (HR 2.05; 95% CI 1.05-4.02).

 

No doubt, we need to better understand the relationship between microvascular dysfunction and comorbidities, such as insulin resistance or cardiac failure.

 

Coronary flow reserve could be an important risk marker, not only for prospective studies assessing the role of ischemia and revascularization, but also as a target for new anti-inflammatory or hypolipidemic drugs, or neurohormone modulators.

 

Original Title: Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease.

Presenter: Taqueti VR.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

FLAVOUR Trial Substudy: FFR or IVUS in the Assessment of Diabetic Patients

Patients with diabetes often present with more complex coronary artery disease compared to non-diabetic patients, with a higher prevalence of diffuse or multivessel disease....

Mechanical Circulatory Support in Complex Anatomies and Severe Deterioration of Left Ventricular Function

Severe coronary artery disease (CAD) frequently causes left ventricular function deterioration, and is often treated with myocardial revascularization surgery (CABG), especially when ejection fraction...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Unplanned Coronary Angiography After TAVR: Incidence, Predictors, and Outcomes

The importance of assessing coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) is well recognized due to the high prevalence of...

Intravascular Lithotripsy in Calcified Coronary Lesions: Success Predictors

Coronary artery calcification (CAC) is increasingly common in patients undergoing percutaneous coronary intervention (PCI). Intravascular lithotripsy (IVL) has been established as an effective tool...

TAVR Unload: TAVR in Moderate Aortic Stenosis and Ventricular Function Deterioration

Aortic Stenosis (AS) significantly contributes to valvulo-arterial impedance in patients with heart failure and reduced ejection fraction (HFrEF), making it a relevant therapeutic target...